Following functional clustering analysis, the ‘PAR1-mediated thrombin signalling events’ pathway was highly enriched in DEGs, suggesting a possible role of thrombin imbalance and PAR1 signalling amplification in CCM development. The gene discussed is MARK2; the disease is cerebral cavernous malformation.